Monthly Archives: June 2013

April 15 2013 – Genetic variation contributes to pulmonary fibrosis risk

AURORA, Colo. (April 15, 2013) – A newly published study of patients with pulmonary fibrosis has discovered multiple genetic variations that should help with future efforts to treat the disease. Pulmonary fibrosis is a condition where lung tissue becomes thickened, … Continue reading

Posted in Interstitial Lung Disease, IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , , | Leave a comment

April 11 2013 Mast cells have critical role in initializing pulmonary fibrosis

New Rochelle, NY, April 11, 2013—Pulmonary fibrosis is a chronic, deadly disease that affects five million people worldwide. It is irreversible, its cause is poorly understood, and it has a median survival of only about 3 years. A new study … Continue reading

Posted in Interstitial Lung Disease, IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , , , | Leave a comment

April 2 2013 – BioGenerator Invests in Antegrin

Drug discovery company developing compounds for human fibrotic diseases ST. LOUIS (April 2, 2013) — BioGenerator – the non-profit venture development organization of BioSTL – recently closed on an investment in Antegrin Therapeutics through its i6 Project Fund.  The investment … Continue reading

Posted in Interstitial Lung Disease, IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , | Leave a comment

March 27 2013 Pulmonary Fibrosis Foundation Announces Open Registration For International Health Care Conference On Pulmonary Fibrosis

PFF Summit 2013: From Bench to Bedside will be held  December 5-7 in La Jolla, California CHICAGO, March 27, 2013 /PRNewswire-USNewswire/ — The Pulmonary Fibrosis Foundation (PFF) announced today that registration is open for the PFF Summit 2013: From Bench … Continue reading

Posted in Interstitial Lung Disease, IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , , | Leave a comment

March 25 2013 – Scientists identify potential treatment for idiopathic pulmonary fibrosis

Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments. In findings published March 1, 2013, in the … Continue reading

Posted in Interstitial Lung Disease, IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , , | Leave a comment

March 21 2013 New procedure gives hope to lung transplant patients – video!

A revolutionary surgery at UCLA Medical Center may change the way the medical community performs transplants. NBC’s Dr. Nancy Snyderman reports on the procedure that involves keeping transplant lungs “breathing” outside the body. See the video at: http://www.today.com/video/today/51270034#51270034 For more … Continue reading

Posted in Interstitial Lung Disease, IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , , , | Leave a comment

March 14 2013 Oldest patient in Ky. to receive lung transplant gets new lease on life

LOUISVILLE,  Ky. —An Illinois man is getting a second lease on life that he never  expected. Bill Ray suffered from pulmonary fibrosis and had about one  year to live without a lung transplant. Since he is 73, he was past … Continue reading

Posted in Interstitial Lung Disease, IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , | Leave a comment

February 22 2013 Inhibition” of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis

Matrix stiffening and myofibroblast resistance to apoptosis are cardinal features of chronic fibrotic diseases involving diverse organ systems. The interactions between altered tissue biomechanics and cellular signaling that sustain progressive fibrosis are not well defined. In this study, we used … Continue reading

Posted in Interstitial Lung Disease, IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , | Leave a comment

January 17 2013 Game changing therapy for Idiopathic Pulmonary Fibrosis now available in Canada.

BURLINGTON, ON, Jan. 17, 2013 /CNW/ – When diagnosed with idiopathic pulmonary fibrosis (IPF), a progressive, debilitating and ultimately fatal disease of the lungs, patients have had minimal treatment options – until today. Following Health Canada’s market approval of Esbriet™ … Continue reading

Posted in Interstitial Lung Disease, IPF, Lung Cancer, Medical, Pulmonary Fibrosis | Tagged , , , , , , , , , , , , | Leave a comment

January 16 2013 Genoa Pharmaceuticals and McMaster University to collaborate on Idiopathic Pulmonary Fibrosis Research

SAN DIEGO, Jan. 16, 2013 /PRNewswire/ — Genoa Pharmaceuticals, a leader in the field of pulmonary fibrosis, today announced it is collaborating with Dr. Martin Kolb and researchers at McMaster University to characterize the in vivo advantages and potential clinical … Continue reading

Posted in Interstitial Lung Disease, IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , | Leave a comment